154 related articles for article (PubMed ID: 6106987)
1. [The cyclic nucleotide system of Aspergillus nidulans under the influence of methylbenzimidazol-2-ylcarbamate (MBC). I. A hypothetical mitosis model].
Künkel W; Römer W
Z Allg Mikrobiol; 1980; 20(3):195-207. PubMed ID: 6106987
[TBL] [Abstract][Full Text] [Related]
2. [Antimitotic activity of methylbenzimidazol-2-yl-carbamate (MBC). I. Light, electron microscopic and physiological studies of germinating conidia of Aspergillus nidulans].
Künkel W
Z Allg Mikrobiol; 1980; 20(2):113-20. PubMed ID: 6990640
[TBL] [Abstract][Full Text] [Related]
3. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
Hickie RA
Adv Exp Med Biol; 1977 May 22-24; 92():451-88. PubMed ID: 24988
[No Abstract] [Full Text] [Related]
5. The effects of light on cyclic nucleotide metabolism of isolated cone photoreceptors.
Denton TL; Yamashita CK; Farber DB
Exp Eye Res; 1992 Feb; 54(2):229-37. PubMed ID: 1348477
[TBL] [Abstract][Full Text] [Related]
6. [Changes in cyclic nucleotide metabolism in compensatory adrenal hypertrophy (following unilateral adrenalectomy)].
Iudaev NA; Afinogenova SA; Zhukova TV
Probl Endokrinol (Mosk); 1982; 28(6):59-66. PubMed ID: 6130520
[TBL] [Abstract][Full Text] [Related]
7. Age-induced differentiation of morphine's effect on cyclic nucleotide metabolism.
Hoskins B; Ho IK
Neurobiol Aging; 1987; 8(5):473-6. PubMed ID: 2891056
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide metabolism in solid tumor tissues.
Criss WE; Muganda P; Sahai A; Morris HP
Adv Exp Med Biol; 1977 May 22-24; 92():489-516. PubMed ID: 24989
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
[No Abstract] [Full Text] [Related]
11. Functional identification of phosphodiesterase activity in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
J Ocul Pharmacol Ther; 2000 Aug; 16(4):317-22. PubMed ID: 10977127
[TBL] [Abstract][Full Text] [Related]
12. Cyclic nucleotide content and granule cell degeneration in the developing cerebellum of staggerer mice.
Spinka K; Farber DB; Lolley RN
J Neurochem; 1980 Jun; 34(6):1531-4. PubMed ID: 6103918
[No Abstract] [Full Text] [Related]
13. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
Sutor B; Mantell K; Bacher B
Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
[TBL] [Abstract][Full Text] [Related]
14. Theoretical analyses of the functioning of the high- and low-Km cyclic nucleotide phosphodiesterases in the regulation of the concentration of adenosine 3',5'-cyclic monophosphate in animal cells.
Fell DA
J Theor Biol; 1980 May; 84(2):361-85. PubMed ID: 6251314
[No Abstract] [Full Text] [Related]
15. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
[TBL] [Abstract][Full Text] [Related]
17. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
DeRubertis FR; Craven PA
Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide metabolism in the mouse spleen after treatment with tilorone hydrochloride.
Römer W; Zschiesche W
Acta Biol Med Ger; 1979; 38(5-6):791-4. PubMed ID: 43058
[No Abstract] [Full Text] [Related]
19. The cGMP system in irradiated animals. Changes in cGMP content and activities of guanylate cyclase and cyclic nucleotide phosphodiesterase.
Sobolev AS; Tertov VV; Rybalkin SD
Acta Radiol Oncol; 1984; 23(5):367-73. PubMed ID: 6150603
[TBL] [Abstract][Full Text] [Related]
20. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
